Corrigendum to "Uterine mesenchymal tumors: a review of selected topics" [Diagn Histopathol, 14 (2008) 175-188] (DOI:10.1016/j.mpdhp.2008.02.009);Uterine mesenchymal tumors: a review of selected topics

Diagnostic Histopathology

Volumn 14, Issue 4, 2008, Pages 175-188

  Soslow, Robert A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

carcinosarcoma; endometrial stromal sarcoma; leiomyosarcoma; malignant mixed Mullerian tumor; uterus

Indexed keywords

ADENOMYOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CARCINOSARCOMA; DIFFERENTIAL DIAGNOSIS; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM SARCOMA; ENDOMETRIUM TUMOR; EPITHELIUM TUMOR; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; LEIOMYOMATOSIS; LEIOMYOSARCOMA; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMOMA; MIXED MULLERIAN TUMOR; UTERUS CANCER;

EID: 41549166181     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2008.05.002     Document Type: Erratum

References (148)

1. Koss L.G., Shapiro R.H., and Brunschwig A. Endometrial stromal sarcoma. Surg Gynecol Obstet 121 (1965) 531-537
2. Major F.J., Blessing J.A., Silverberg S.G., et al. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71 (1993) 1702-1709
3. de Fusco P.A., Gaffey T.A., Malkasian Jr. G.D., Long H.J., and Cha S.S. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980. Gynecol Oncol 35 (1989) 8-14
4. Chang K.L., Crabtree G.S., Lim-Tan S.K., Kempson R.L., and Hendrickson M.R. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 14 (1990) 415-438
5. Kempson R.L., and Hendrickson M.R. Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus. Mod Pathol 13 (2000) 328-342
6. Norris H.J., and Taylor H.B. Mesenchymal tumors of the uterus I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19 (1966) 755-766
7. Oliva E., Clement P.B., and Young R.H. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol 7 (2000) 257-281
8. Tavassoli F.A., and Norris H.J. Mesenchymal tumours of the uterus. VII. A clinicopathological study of 60 endometrial stromal nodules. Histopathology 5 (1981) 1-10
9. Evans H.L. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 50 (1982) 2170-2182
10. Piver M.S., Rutledge F.N., Copeland L., Webster K., Blumenson L., and Suh O. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 64 (1984) 173-178
11. McCluggage W.G., Haller U., Kurman R.J., and Kubik-Huch R.A. Mixed epithelial and mesenchymal tumours. In: Tavassoli F.A., and Devilee P. (Eds). World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon 245-249
12. Malpica A., Deavers M.T., and Silva E.G. High-grade sarcoma in endometrial stromal sarcoma: dedifferentiated endometrial stromal sarcoma. Mod Pathol 19 (2006) 188A (abstract 872)
13. Maluf F.C., Sabbatini P., Schwartz L., et al. Endometrial stromal sarcoma: objective response to letrozole. Gynecol Oncol 82 (2001) 384-388
14. Chu M.C., Mor G., Lim C., et al. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90 (2003) 170-176
15. Schilder J.M., Hurd W.W., Roth L.M., et al. Hormonal treatment of an endometrial stromal nodule followed by local excision. Obstet Gynecol 93 (1999) 805-807
16. Clement P.B. The pathology of uterine smooth muscle tumors and mixed endometrial stromal-smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 19 (2000) 39-55
17. McCluggage W.G., Cromie A.J., Bryson C., et al. Uterine endometrial stromal sarcoma with smooth muscle and glandular differentiation. J Clin Pathol 54 (2001) 481-483
18. Oliva E., Clement P.B., Young R.H., et al. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases. Am J Surg Pathol 22 (1998) 997-1005
19. Silverberg S.G., and Kurman R.J. Atlas of tumor pathology: tumors of the uterine corpus and gestational trophoblastic disease Vol. 3 (1992), Armed Forces Institute of Pathology, Washington, DC p. 141-146
20. Yilmaz A., Rush D.S., and Soslow R.A. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol 26 (2002) 1142-1150
21. Oliva E., Young R.H., Clement P.B., et al. Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int J Gynecol Pathol 18 (2002) 310-319
22. Fukunaga M., Miyazawa Y., and Ushigome S. Endometrial low-grade stromal sarcoma with ovarian sex cord-like differentiation: report of two cases with an immunohistochemical and flow cytometric study. Pathol Int 47 (1997) 412-415
23. Ohta Y., Suzuki T., Kojima M., et al. Low-grade endometrial stromal sarcoma with an extensive epithelial-like element. Pathol Int 53 (2003) 246-251
24. Oliva E., Clement P.B., and Young R.H. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Int J Gynecol Pathol 21 (2002) 48-55
25. Clement P.B., and Scully R.E. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 11 (1992) 163-173
26. Levine P.H., Abou-Nassar S., and Mittal K. Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation. Int J Gynecol Pathol 20 (2001) 395-398
27. Baker P.M., Moch H., and Oliva E. Unusual morphologic features of endometrial stromal tumors: a report of 2 cases. Am J Surg Pathol 29 (2005) 1394-1398
28. Aubry M.C., Myers J.L., Colby T.V., Leslie K.O., and Tazelaar H.D. Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients. Am J Surg Pathol 26 (2002) 440-449
29. Abrams J., Talcott J., and Corson J.M. Pulmonary metastases in patients with low-grade endometrial stromal sarcoma: clinicopathologic findings with immunohistochemical characterization. Am J Surg Pathol 13 (1989) 133-140
30. Clement P.B., Young R.H., and Scully R.E. Intravenous leiomyomatosis of the uterus: a clinicopathologic analysis of 16 cases with unusual histologic features. Am J Surg Pathol 12 (1988) 932-945
31. Tench W.D., Dail D., Gmelich J.T., et al. Benign metastasizing leiomyomas: a review of 21 cases. Lab Invest 38 (1978) 367 (abstract)
32. Traweek S.T., Rotter A.J., Swartz W., et al. Cystic pulmonary metastatic sarcoma. Cancer 65 (1990) 1805-1811
33. Wolff M., Kaye G., and Silva F. Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms: report of nine cases, including three males. Am J Surg Pathol 3 (1979) 325-342
34. Bhargava R., Shia J., Hummer A.J., Thaler H.T., Tornos C., and Soslow R.A. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains. Mod Pathol 18 (2005) 40-47
35. Chu P., and Arber D.A. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113 (2000) 374-382
36. Chu P.G., Arber D.A., Weiss L.M., and Chang K.L. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14 (2001) 465-471
37. McCluggage W.G., Sumathi V.P., and Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39 (2001) 273-278
38. Oliva E., Young R.H., Amin M.B., and Clement P.B. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26 (2002) 403-412
39. Sumathi V.P., Al-Hussaini M., Connolly L.E., Fullerton L., and McCluggage W.G. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol 23 (2004) 241-247
40. Sabini G., Chumas J.C., and Mann W.J. Steroid hormone receptors in endometrial stromal sarcomas. A biochemical and immunohistochemical study. Am J Clin Pathol 97 (1992) 381-386
41. Franquemont D.W., Frierson Jr. H.F., and Mills S.E. An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation. Am J Surg Pathol 15 (1991) 861-870
42. Nucci M.R., O'Connell J.T., Huettner P.C., Cviko A., Sun D., and Quade B.J. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25 (2001) 455-463
43. Rush D.S., Tan J., Baergen R.N., and Soslow R.A. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25 (2001) 253-258
44. Rossi G., Cavazza A., Longo L., and Maiorana A. Localized pleural metastatic adenosarcoma of the uterine cervix mimicking a malignant solitary fibrous tumour: CD10 has no value in differential diagnosis. Histopathology 41 (2002) 82-88
45. Bongiovanni M., Viberti L., Pecchioni C., et al. Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells. J Pathol 198 (2002) 252-257
46. Fukunaga M. Atypical solitary fibrous tumor of the vulva. Int J Gynecol Pathol 19 (2000) 164-168
47. Krishnamurthy S., Jungbluth A.A., Busam K.J., and Rosai J. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol 22 (1998) 1078-1082
48. Baker R.J., Hildebrandt R.H., Rouse R.V., Hendrickson M.R., and Longacre T.A. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol 30 (1999) 671-679
49. Irving J.A., Carinelli S., and Prat J. Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol 19 (2006) 17-24
50. de Leval L., Waltregny D., Dupuis L.M., Boniver J., and Oliva E. Uterine tumors resembling ovarian sex-cord tumors. A study of 13 cases showing a diverse phenotypic profile. Mod Pathol 19 (2006) 176A
51. Oliva E., de Leval L., Soslow R.A., and Herens C. High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol 31 (2007) 1277-1284
52. Nucci M.R., Harburger D., Koontz J., Cin P.D., and Sklar J. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 31 (2007) 65-70
53. Huang H.Y., Ladanyi M., and Soslow R.A. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity. Am J Surg Pathol 28 (2004) 224-232
54. Koontz J.I., Soreng A.L., Nucci M., et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA 98 (2001) 6348-6353
55. Dionigi A., Oliva E., Clement P.B., and Young R.H. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 26 (2002) 567-581
56. Oliva E., Young R.H., Clement P.B., Bhan A.K., and Scully R.E. Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19 (1995) 757-768
57. Evans H.L., Chawla S.P., Simpson C., and Finn K.P. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62 (1988) 2239-2247
58. Norris H.J., and Parmley T. Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases. Cancer 36 (1975) 2164-2178
59. Kurman R.J., and Norris H.J. Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear-cell leiomyoma: a clinical and pathologic analysis of 26 cases. Cancer 37 (1976) 1853-1865
60. Prayson R.A., Goldblum J.R., and Hart W.R. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients. Am J Surg Pathol 21 (1997) 383-391
61. Clement P.B., and Scully R.E. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol 66 (1976) 512-525
62. Harlow B.L., Weiss N.S., and Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76 (1986) 399-402
63. Bell S.W., Kempson R.L., and Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18 (1994) 535-558
64. Gadducci A., Ferdeghini M., Prontera C., et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol 44 (1992) 147-154
65. Leibsohn S., d'Ablaing G., Mishell Jr. D.R., and Schlaerth J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162 (1990) 968-974 (discussion 974-976)
66. Parker W.H., Fu Y.S., and Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83 (1994) 414-418
67. Barter J.F., Smith E.B., Szpak C.A., Hinshaw W., Clarke-Pearson D.L., and Creasman W.T. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol 21 (1985) 220-227
68. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., and Lewis Jr. J.L. Treatment of uterine leiomyosarcoma. Obstet Gynecol 71 6 Pt 1 (1988) 845-850
69. Burns B., Curry R.H., and Bell M.E. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases. Am J Obstet Gynecol 135 (1979) 109-114
70. Larson B., Silfversward C., Nilsson B., and Pettersson F. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol 29 (1990) 185-191
71. Wheelock J.B., Krebs H.B., Schneider V., and Goplerud D.R. Uterine sarcoma: analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 151 (1985) 1016-1022
72. Kahanpaa K.V., Wahlstrom T., Grohn P., Heinonen E., Nieminen U., and Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67 (1986) 417-424
73. Marchese M.J., Liskow A.S., Crum C.P., McCaffrey R.M., and Frick II H.C. Uterine sarcomas: a clinicopathologic study, 1965-1981. Gynecol Oncol 18 (1984) 299-312
74. Mayerhofer K., Obermair A., Windbichler G., et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74 (1999) 196-201
75. Nola M., Babic D., Ilic J., et al. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 78 (1996) 2543-2550
76. Nordal R.R., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., and Trope C.G. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 34 (1995) 797-802
77. Pautier P., Genestie C., Rey A., et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88 (2000) 1425-1431
78. Wolfson A.H., Wolfson D.J., Sittler S.Y., et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52 (1994) 56-62
79. Wang W.L., Soslow R.A., Hensley M., et al. Histologic prognostic factors in stage I uterine leiomyosarcoma: a clinicopathologic study of 28 cases. Mod Pathol 20 (2007) 217A (abstract 994)
80. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., Leodolter S., and Mayerhofer K. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study. J Reprod Med 48 (2003) 95-100
81. Hsieh C.H., Lin H., Huang C.C., Huang E.Y., Chang S.Y., and ChangChien C.C. Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstet Gynecol Scand 82 (2003) 74-81
82. Jones M.W., and Norris H.J. Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14 (1995) 243-249
83. Giuntoli II R.L., Metzinger D.S., DiMarco C.S., et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89 (2003) 460-469
84. Giuntoli 2nd RL, Gostout BS, DiMarco CS, et al. Diagnostic criteria for uterine smooth muscle tumors: continued refinement is necessary. In: Thirty-sixth annual meeting on women's cancer of the society of gynecologic oncologists. Miami, FL, USA; March 2005 (abstract 228).
85. Omura G.A., Major F.J., Blessing J.A., et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52 (1983) 626-632
86. Currie J., Blessing J.A., Muss H.B., Fowler J., Berman M., and Burke T.W. Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study. Gynecol Oncol 61 (1996) 27-30
87. Sutton G., Blessing J.A., and Malfetano J.H. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol 62 (1996) 226-229
88. Hensley M.L., Maki R., Venkatraman E., et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20 (2002) 2824-2831
89. Hensley M.L., Anderson S., Soslow R.A., et al. Activity of dose rate-based gemcitabine plus docetaxel in leiomyosarcoma (LMS) and other histologies: report of an expanded phase II trial. Proc Amer Soc Clin Oncol 23 (2004)
90. Omura G.A., Blessing J.A., Major F., et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol 3 (1985) 1240-1245
91. Hensley ML. Uterine sarcomas: advances for advanced disease and updates on adjuvant therapy. In: American society of clinical oncology 2006 educational book, 2006, p. 301-304.
92. Hornback N.B., Omura G., and Major F.J. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12 (1986) 2127-2130
93. Atkins K., Bell S., Kempson R., and Hendrickson M. Myxoid smooth muscle tumors of the uterus. Mod Pathol 14 (2001) 132A
94. King M.E., Dickersin G.R., and Scully R.E. Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 6 (1982) 589-598
95. Atkins K., Bell S., Kempson R., and Hendrickson M. Epithelioid smooth muscle tumors of the uterus. Mod Pathol 14 (2001) 132A
96. Rizeq M.N., van de Rijn M., Hendrickson M.R., and Rouse R.V. A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Hum Pathol 25 (1994) 671-677
97. Zhai Y.L., Kobayashi Y., Mori A., et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18 (1999) 20-28
98. Mittal K., and Demopoulos R.I. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol 32 (2001) 984-987
99. Leitao M.M., Soslow R.A., Nonaka D., et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101 (2004) 1455-1462
100. Anderson S.E., Nonaka D., Chuai S., et al. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. Int J Gynecol Cancer 16 (2006) 849-853
101. Hall K.L., Teneriello M.G., Taylor R.R., et al. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol 65 (1997) 330-335
102. Zhai Y.L., Nikaido T., Orii A., Horiuchi A., Toki T., and Fujii S. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma. Gynecol Oncol 75 (1999) 453-459
103. Amada S., Nakano H., and Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 14 (1995) 134-142
104. Esteban J.M., Allen W.M., and Schaerf R.H. Benign metastasizing leiomyoma of the uterus: histologic and immunohistochemical characterization of primary and metastatic lesions. Arch Pathol Lab Med 123 (1999) 960-962
105. Tietze L., Gunther K., Horbe A., et al. Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease. Hum Pathol 31 (2000) 126-128
106. Tavassoli F.A., and Norris H.J. Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1 (1982) 59-74
107. Nucci M.R., Drapkin R., Cin P.D., Fletcher C.D., and Fletcher J.A. Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol 31 (2007) 737-743
108. Folpe A.L., Goodman Z.D., Ishak K.G., et al. Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol 24 (2000) 1239-1246
109. Vang R., and Kempson R.L. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26 (2002) 1-13
110. Silva E.G., Deavers M.T., Bodurka D.C., and Malpica A. Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28 (2004) 244-249
111. Fukunaga M. Perivascular epithelioid cell tumor of the uterus: report of four cases. Int J Gynecol Pathol 24 (2005) 341-346
112. Folpe A.L., Mentzel T., Lehr H.A., Fisher C., Balzer B.L., and Weiss S.W. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29 (2005) 1558-1575
113. Simpson K.W., and Albores-Saavedra J. HMB-45 reactivity in conventional uterine leiomyosarcomas. Am J Surg Pathol 31 (2007) 95-98
114. Oliva E., Wang W.L., Logani S., et al. Expression of melanocytic ("PEComa") markers in smooth muscle tumors of the uterus: an immunohistochemical analysis of 86 cases. Mod Pathol 19 (2006) 191A (abstract 884)
115. Kurman R.J., Scully R.E., and Norris H.J. Trophoblastic pseudotumor of the uterus: an exaggerated form of "syncytial endometritis" simulating a malignant tumor. Cancer 38 (1976) 1214-1226
116. Young R.H., Kurman R.J., and Scully R.E. Proliferations and tumors of intermediate trophoblast of the placental site. Semin Diagn Pathol 5 (1988) 223-237
117. Baergen R.N., Rutgers J.L., Young R.H., Osann K., and Scully R.E. Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100 (2006) 511-520
118. Bitterman P., Chun B., and Kurman R.J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol 14 (1990) 317-328
119. McCluggage W.G. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol 55 (2002) 321-325
120. McCluggage W.G. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12 (2002) 687-690
121. Sreenan J.J., and Hart W.R. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 19 (1995) 666-674
122. Silverberg S.G., Major F.J., Blessing J.A., et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9 (1990) 1-19
123. Yamada S.D., Burger R.A., Brewster W.R., Anton D., Kohler M.F., and Monk B.J. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 88 (2000) 2782-2786
124. George E., Lillemoe T.J., Twiggs L.B., and Perrone T. Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. Int J Gynecol Pathol 14 (1995) 39-44
125. Soslow R.A., Bissonnette J.P., Wilton A., et al. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Am J Surg Pathol 31 (2007) 979-987
126. Alektiar K.M., McKee A., Lin O., et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer?. Int J Radiat Oncol Biol Phys 54 (2002) 79-85
127. Ferguson S.E., Tornos C., Hummer A., Barakat R.R., and Soslow R.A. Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31 (2007) 1653-1661
128. Ferguson S.E., Gerald W., Barakat R.R., Chi D.S., and Soslow R.A. Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. Am J Surg Pathol 31 (2007) 382-389
129. Shokeir M.O., Noel S.M., and Clement P.B. Malignant mullerian mixed tumor of the uterus with a prominent alpha-fetoprotein-producing component of yolk sac tumor. Mod Pathol 9 (1996) 647-651
130. Yamamoto Y., Akagi A., Izumi K., and Kishi Y. Carcinosarcoma of the uterine body of mesonephric origin. Pathol Int 45 (1995) 303-309 (Erratum in: Pathol Int 1995; 45: 541)
131. Baschinsky D.Y., Niemann T.H., Eaton L.A., and Frankel W.L. Malignant mixed Mullerian tumor with rhabdoid features: a report of two cases and a review of the literature. Gynecol Oncol 73 (1999) 145-150
132. Fukunaga M., Nomura K., Endo Y., Ushigome S., and Aizawa S. Carcinosarcoma of the uterus with extensive neuroectodermal differentiation. Histopathology 29 (1996) 565-570
133. Amant F., Moerman P., Davel G.H., et al. Uterine carcinosarcoma with melanocytic differentiation. Int J Gynecol Pathol 20 (2001) 186-190
134. Cokelaere K., Michielsen P., De Vos R., and Sciot R. Primary mesenteric malignant mixed mesodermal (mullerian) tumor with neuroendocrine differentiation. Mod Pathol 14 (2001) 515-520
135. Donner L.R., Wainwright L.M., Zhang F., and Biegel J.A. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol 38 (2007) 935-939
136. Dupont J., Wang X., Marshall D.S., et al. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecol Oncol 94 (2004) 449-455
137. Chitale D.A., and Soslow R.A. Epidermal growth factor receptor (EGFR) protein overexpression is significant in endometrial carcinosarcoma in contrast to other endometrial carcinomas and is not associated with EGFR gene amplification. Mod Pathol 20 (2007) 192A (abstract 878)
138. Cimbaluk D., Rotmensch J., Scudiere J., Gown A., and Bitterman P. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol Oncol 105 (2007) 138-144
139. Livasy C.A., Reading F.C., Moore D.T., Boggess J.F., and Lininger R.A. EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma. Gynecol Oncol 100 (2006) 101-106
140. Amant F., Vloeberghs V., Woestenborghs H., et al. ERBB-2 gene overexpression and amplification in uterine sarcomas. Gynecol Oncol 95 (2004) 583-587
141. Murray S.K., Clement P.B., and Young R.H. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 29 (2005) 157-166
142. Tornos C., Silva E.G., Ordonez N.G., Gershenson D.M., Young R.H., and Scully R.E. Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases. Am J Surg Pathol 19 (1995) 1343-1353
143. Silva E.G., Deavers M.T., Bodurka D.C., and Malpica A. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?. Int J Gynecol Pathol 25 (2006) 52-58
144. Altrabulsi B., Malpica A., Deavers M.T., Bodurka D.C., Broaddus R., and Silva E.G. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 29 (2005) 1316-1321
145. Clement P.B., and Scully R.E. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21 (1990) 363-381
146. Clement P.B. Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol 13 (1989) 28-38
147. Zaloudek C.J., and Norris H.J. Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer 48 (1981) 354-366
148. Seidman J.D., and Chauhan S. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas. Int J Gynecol Pathol 22 (2003) 75-82